Peri-operative Application of Eyeprotx General Anesthesia Goggles As Prevention Against Corneal Injury Post Intubation.

Sponsor
University of Miami (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03762889
Collaborator
(none)
0
1
3
6
0

Study Details

Study Description

Brief Summary

This is a randomized controlled trial that seeks to examine the effectiveness of Eyeprotx™ protective goggles in comparison to traditional methods against ocular injury that can occur perioperatively under general anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Device: Eyeprotx™ General Anesthesia Protective Goggles
  • Device: Eyelid Tape
  • Device: Eye Ointment
N/A

Detailed Description

Ocular injury is but a devastating condition that can occur perioperatively under general anesthesia. Corneal abrasion is the most common ocular injury during general anesthesia, surpassing case incidence of damage caused by patient movement in ophthalmologic surgery. Causes of ocular injury include corneal drying due to the suppression of tear ducts from anesthetic agents, direct physical trauma, or agitation from the volatile anesthetic used. Ocular injury may also occur due to bacterial infection with MRSA, preventative methods, or rubbing of the eyes postoperatively due to agitation. Agitation may be caused by corneal drying or by shift or disruption in rapid eye movement sleep cycle from light penetration through the eyelids. Attempts at prevention of corneal abrasion have been used, including taping the eyelids shut, manual eye closure, paraffin-based ointment application into the conjunctival sac, and the use of hydrophilic contact lenses, although only a few studies have validated the comparison of these methods' effectiveness.

Eyeprotx™ Protective Goggles have been designed specifically for use in the operating room or in any scenario where general anesthesia must be used, such as intubation in an emergency. Current ocular protective measures such as tapes during anesthesia have been associated with injury and infection. With this study, we hope to find a safer preventative technique against ocular injury during the perioperative period.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
In this cohort study, 100 preoperative patients from Jackson Memorial Hospital would be randomly assigned based on age, gender, and type of anesthesia to three samples: anesthesia with Eyeprotx™ Goggles, anesthesia with eyelid tape, and anesthesia with ointment application. Analysis of samples will be based on length of procedure, length of preventative measure application, position during operation(supine or prone), and postoperative events. Patient discomfort or pain, eye dryness intensity would be rated on numerical rating scale. Qualitative analysis will include additional comments from patients and the anesthesiologist.In this cohort study, 100 preoperative patients from Jackson Memorial Hospital would be randomly assigned based on age, gender, and type of anesthesia to three samples: anesthesia with Eyeprotx™ Goggles, anesthesia with eyelid tape, and anesthesia with ointment application. Analysis of samples will be based on length of procedure, length of preventative measure application, position during operation(supine or prone), and postoperative events. Patient discomfort or pain, eye dryness intensity would be rated on numerical rating scale. Qualitative analysis will include additional comments from patients and the anesthesiologist.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Peri-operative Application of EYEPROTX General Anesthesia Protective Goggles as an Effective Modality to Reduce the Incidence of Corneal Injury Post-Intubation.
Anticipated Study Start Date :
Jun 1, 2019
Anticipated Primary Completion Date :
Dec 1, 2019
Anticipated Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Eyeprotx™ Group

This group of participants will use the Eyeprotx™ General Anesthesia Protective Goggles when intubated perioperatively under general anesthesia.

Device: Eyeprotx™ General Anesthesia Protective Goggles
Eyeprotx™ Protective Goggles have been designed specifically for use in the operating room or in any scenario where general anesthesia must be used, such as intubation in an emergency. The integral function is to reduce intraocular pressure while in place, prevent operating room bright light penetration, facilitate a swift placement preventative measure with straps, form a barrier against bacterial invasion and mechanical damage. This study would seek to examine this goggles' effectiveness as a preventative measure as vs. other measures.

Active Comparator: Eyelid Tape Group

This group of participants will be receiving the eyelid tape as the preventative measure when intubated perioperatively under general anesthesia.

Device: Eyelid Tape
Taping the eyelids during intubation is one of the standard techniques used perioperatively under general anesthesia. This intervention would be used for the Eyelid Tape Group.

Active Comparator: Eye Ointment Group

This group of participants will be receiving the ointment application when intubated perioperatively under general anesthesia.

Device: Eye Ointment
Another standard technique used perioperatively under general anesthesia is to apply an ointment to the eye for lubrication. This intervention would be applied to the Eye Ointment Group.

Outcome Measures

Primary Outcome Measures

  1. Changes in Baseline Ocular Condition post-operatively [The patient's initial rating will be recorded approximately ten minutes before surgery at the point of anesthesia evaluation and will be reassessed up to 24 hours post-operatively.]

    The following will be measured upon evaluation, using a numerical scale of 1 to 8, with 1 being complete absence of condition and 8 being the most severe presentation of the condition: 1. eye discomfort, 2, pain, and 3. dryness intensity, each on a numerical rating-scale of 1 to 8, The measures will be compared among the goggle, ointment, and tape groups.

  2. Incidence of Ocular Complications post-operation [Evaluation of these complications will be done from the point the patient has returned to the recovery room to up to one week post-surgery or until discharge, whichever comes first.]

    Incidence of corneal abrasion, conjunctivitis, MRSA infection, and direct ocular trauma will be assessed by the anesthesiologist or nurse anesthetist and will be recorded upon diagnosis of condition for all groups.

Secondary Outcome Measures

  1. Patient Awareness during Anesthesia [This measure will be evaluated up to 48 hours post-surgical operation.]

    Patient awareness of being under anesthesia will be recorded qualitatively, with accounts of anxiety and/or fear being noted, if applicable.

  2. Incidence of Nightmare during Use [This measure will be evaluated up to 48 hours post-surgical operation.]

    Patient's report of experiencing nightmares during the surgery will be recorded qualitatively.

Other Outcome Measures

  1. Usability Scale Per Operator [This measure will be evaluated up to 6 months after the post-surgical operation.]

    The anesthesiologists and nurse anesthetists working on the trial will be asked to complete a usability scale questionnaire to evaluate the effectiveness of the different variation of the goggles, such as goggles with a strap versus goggles with short sterilized adhesive tape.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients undergoing general anesthesia

  • Patients admitted to Jackson Memorial Hospital

Exclusion Criteria:
  • Patients unable to communicate, for whatever reason

  • Patients predisposed to eye conditions

  • Patients with history of increased intraocular pressure

  • Patients with a medical history of Sicca syndrome

  • Patients with claustrophobia

  • Patients with pseudoexfoliation syndromes

  • Patients with a current exopthalmic condition

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jackson Memorial Hospital Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami

Investigators

  • Principal Investigator: Adam M Au, DO MD PHD, Jackson Health System

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Leo Kleyman, Research Fellow, University of Miami
ClinicalTrials.gov Identifier:
NCT03762889
Other Study ID Numbers:
  • 20180875
First Posted:
Dec 4, 2018
Last Update Posted:
Jun 6, 2019
Last Verified:
Jun 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 6, 2019